Antiplatelet drug
Showing 1 - 25 of >10,000
Anticoagulant Drug Intervention on Postoperative MALE and MACE
Recruiting
- Anticoagulant Drugs
- +2 more
- anticoagulant or antiplatelet drugs
-
Hangzhou, None Selected, ChinaFirst Affiliated Hospital of Zhejiang University
May 8, 2023
Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Recruiting
- Cardiac Arrest
- +3 more
- Antiplatelet Drug
-
Monza, MB, ItalyIRCCS San Gerardo dei Tintori
Feb 14, 2023
Elevated Lipoprotein(a) Level, Coronary Artery Disease, Drug-Eluting Stent Trial in Beijing (24 Months DAPT, 12 Months DAPT)
Not yet recruiting
- Elevated Lipoprotein(a) Level
- +3 more
- 24 Months DAPT
- 12 Months DAPT
-
Beijing, Beijing, ChinaFuwai Hospital, National Center for Cardiovascular Diseases, Chi
Aug 26, 2023
Type 2 Diabetes With Antiplatelet Drugs
Enrolling by invitation
- Type2 Diabetes
- +3 more
- Antiplatelet Drug
-
Orlando, FloridaTabula Rasa Healthcare
Dec 17, 2021
Stroke, Carotid Web Trial in Barcelona (Antiplatelet Drug, Anticoagulant, Endovascular)
Recruiting
- Stroke
- Carotid Web
- Antiplatelet Drug
- +3 more
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Jul 28, 2022
Acute Ischemic Stroke Trial in Toledo (procedure, drug, device)
Recruiting
- Acute Ischemic Stroke
- Intra-arterial Therapy
- +2 more
-
Toledo, OhioMercy Health St. Vincent Medical Center
Nov 2, 2022
Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)
Not yet recruiting
- Coronary Heart Disease
- Ticagrelor
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Left Main Coronary Artery Stenosis Trial in Geneva (LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International,
Not yet recruiting
- Left Main Coronary Artery Stenosis
- LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International, Switzerland)
- +2 more
-
Geneva, SwitzerlandGeneva University Hospitals
Jan 12, 2023
Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon Trial in Xi'an (Aspirin 100mg for 1-month (immediately after
Recruiting
- Antiplatelet Drug
- +2 more
- Aspirin 100mg for 1-month (immediately after PCI)
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Myocardial Infarction Type 2 Trial (Coronary computed tomography angiography, Invasive coronary angiography, Transthoracic
Not yet recruiting
- Myocardial Infarction Type 2
- Coronary computed tomography angiography
- +7 more
- (no location specified)
Jun 15, 2022
Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent
Active, not recruiting
- Coronary Artery Disease
- Atheroscleroses, Coronary
- Antiplatelet Agents
- (no location specified)
Oct 1, 2022
Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,
Not yet recruiting
- Ischemic Stroke
- Vertebral Artery Stenosis
- Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
- +2 more
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 1, 2023
Acute Coronary Syndrome Trial (Drug-coated stent, Drug-eluting stent)
Not yet recruiting
- Acute Coronary Syndrome
- Drug-coated stent
- Drug-eluting stent
- (no location specified)
Apr 7, 2022
Antiplatelet Drugs Trial in India, Korea, Republic of, Turkey (Aspirin only, No antiplatelet therapy)
Recruiting
- Antiplatelet Drugs
- Aspirin only
- No antiplatelet therapy
-
Mumbai, India
- +34 more
Feb 2, 2023
Coronary Artery Disease Trial in Seoul (1 Month vs. 12 Months DAPT)
Recruiting
- Coronary Artery Disease
- 1 Month vs. 12 Months DAPT
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Mar 5, 2023
Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack Trial in Korea, Republic of (Antiplatelet Drug, Warfarin)
Not yet recruiting
- Antiphospholipid Syndrome
- +5 more
- Antiplatelet Drug
- Warfarin
-
Anyang, Korea, Republic of
- +34 more
Aug 15, 2023
Coronary Artery Disease Trial in Seoul (Type of stent, Duration of DAPT)
Recruiting
- Coronary Artery Disease
- Type of stent
- Duration of DAPT
-
Seoul, Korea, Republic ofSamsung Medical Center
May 8, 2022
High Ischemic Risk Trial in Seoul (Ticagrelor-based dual-antiplatelet therapy, Clopidogrel-based dual-antiplatelet therapy)
Not yet recruiting
- High Ischemic Risk
- Ticagrelor-based dual-antiplatelet therapy
- Clopidogrel-based dual-antiplatelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Aug 3, 2021
Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,
Completed
- Stable Angina
- +2 more
- 3-months DAPT
- 1-year DAPT
-
Busan, Korea, Republic of
- +11 more
Jan 8, 2023
Thrombectomy, Tandem Occlusion, Stroke Trial in Lishui (device, procedure, drug)
Recruiting
- Thrombectomy
- +2 more
- Carotid Stenting
- +3 more
-
Lishui, Zhejiang, ChinaLishui Municipal Hospital
Jun 13, 2023
Angina, Stable, Acute Coronary Syndrome, Drug-Eluting Stents Trial in Beijing, Xuzhou, Chengdu (CYP2C19 genotype testing)
Recruiting
- Angina, Stable
- +3 more
- CYP2C19 genotype testing
-
Beijing, Beijing, China
- +11 more
Nov 4, 2021
Acute Coronary Syndrome, Drug-Eluting Stents Trial in Iksan (Aspirin, Colchicine)
Recruiting
- Acute Coronary Syndrome
- Drug-Eluting Stents
-
Iksan, Korea, Republic ofWonkwang University Hospital
Jun 25, 2021
Cognition After Aneurysmal Subarachnoid Hemorrhage
Unknown status
- Aneurysmal Subarachnoid Hemorrhage
- Antiplatelet Drug
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Sep 10, 2020